🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

168+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 20 of 168 recruiting trials for “Systemic lupus erythematosus

RecruitingNCT06778343

Biomarkers in Inflammatory Rheumatic Diseases Diagnosis

🏥 Universidade Nova de Lisboa📍 1 site📅 Started Jan 2023View details ↗
Phase 2RecruitingNCT06155604

SGLT2 Inhibitor in Lupus Nephritis Patients With Chronic Kidney Disease

👨‍⚕️ Desmond Yap, MD (HK), The University of Hong Kong📍 1 site📅 Started Jan 2023View details ↗
NARecruitingNCT05612750

Comparative Effectiveness of Online 8-session CBT vs. 1-Session Empowered Relief for Chronic Pain - The PROGRESS Study

🏥 Stanford University📍 5 sites📅 Started Jan 2023View details ↗
Phase 2RecruitingNCT03673748

Treatment of Lupus Nephritis With Allogeneic Mesenchymal Stem Cells

👨‍⚕️ Julia Barbado, MD, PhD, University Hospital Río Hortega, Valladolid, Spain📍 1 site📅 Started Dec 2022View details ↗
NARecruitingNCT06166199

Effects of High-intensity Interval Training in Patients With Systemic Lupus Erythematosus

👨‍⚕️ Carina M Boström, Dr, Karolinska Institutet📍 1 site📅 Started Nov 2022View details ↗
NARecruitingNCT05340881

Systematic Light Exposure in Pediatric Brain Tumor Survivors

👨‍⚕️ Kimberly P Raghubar, PhD, Baylor College of Medicine📍 1 site📅 Started Oct 2022View details ↗
RecruitingNCT06506214

Characterizing Adherence to Treatment and Satisfaction With Care in Patients With Cutaneous Lupus

👨‍⚕️ Carle PAUL, MD, University Hospital, Toulouse📍 4 sites📅 Started Oct 2022View details ↗
Phase 2, PHASE3RecruitingNCT05531565

A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus

👨‍⚕️ Medical Director, Biogen📍 308 sites📅 Started Sep 2022View details ↗
Phase 3RecruitingNCT05126277

Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis

👨‍⚕️ Novartis Pharmaceuticals, Novartis Pharmaceuticals📍 188 sites📅 Started Jul 2022View details ↗
Phase 3Enrolling by InvitationNCT05352919

An Extension Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus

👨‍⚕️ Medical Director, Biogen📍 182 sites📅 Started Jun 2022View details ↗
Phase 2RecruitingNCT05201469

VIBRANT: VIB4920 for Active Lupus Nephritis

👨‍⚕️ Maria Dall'Era, M.D., University of California San Francisco School of Medicine: Lupus Clinic and Rheumatology Clinical Research Center📍 17 sites📅 Started May 2022View details ↗
RecruitingNCT05193591

Anti-C1s, Anti-HMGB1 and Anti-C1q Autoantibodies in Systemic Lupus Erythematosus (DYSALARM-322)

👨‍⚕️ Chantal DUMESTRE-PERARD, Professor, Grenoble Alpes University Hospital📍 2 sites📅 Started Mar 2022View details ↗
NARecruitingNCT04449991

Per-protocol Repeat Kidney Biopsy in Incident Cases of Lupus Nephritis

👨‍⚕️ Ioannis Parodis, MD PhD, Karolinska Institutet📍 1 site📅 Started Jan 2022View details ↗
Phase 3RecruitingNCT04702256

Induction Therapy for Lupus Nephritis With no Added Oral Steroids: A Trial Comparing Oral Corticosteroids Plus Mycophenolate Mofetil (MMF) Versus Obinutuzumab and MMF

👨‍⚕️ Nathalie COSTEDOAT-CHALUMEAU, MD, PhD, Centre de référence maladies auto-immunes et systémiques rares, Internal medicine, Cochin hospital, APHP📍 1 site📅 Started Dec 2021View details ↗
Phase 3Enrolling by InvitationNCT04976322

A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus

👨‍⚕️ UCB Cares, 001 844 599 2273 (UCB)📍 105 sites📅 Started Jul 2021View details ↗
RecruitingNCT04833465

Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions

🏥 Children's National Research Institute📍 1 site📅 Started Jul 2021View details ↗
RecruitingNCT04604990

National Systemic Lupus Erythematosus Prospective Cohort, Saudi Arabia

🏥 King Saud University📍 1 site📅 Started Dec 2020View details ↗
NARecruitingNCT04320680

Systemic Lupus Erythematosus Within the Framework of the Multidisciplinary Consultation

🏥 University Hospital, Brest📍 1 site📅 Started Oct 2020View details ↗
Phase 4RecruitingNCT03543839

Trial of Belimumab in Early Lupus

👨‍⚕️ Cynthia Aranow, MD, Feinstein Institute for Medical Research, Northwell Health📍 1 site📅 Started Sep 2020View details ↗
RecruitingNCT05017142

Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)

👨‍⚕️ Sandra Bigi, PD MD, ISPM, University of Bern, Bern; Kinderspital Zentralschweiz, Luzern📍 13 sites📅 Started Apr 2020View details ↗
← PreviousPage 8 of 9Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →